What High Court's Kisor Ruling Means For FDA Decisions

By Chad Landmon, Alex Alfano and Ashton Copeland (July 16, 2019, 4:34 PM EDT) -- On June 26, 2019, the U.S. Supreme Court issued its opinion in Kisor v. Wilkie, refusing to overturn a longstanding doctrine of deferring to administrative agencies' interpretation of their own regulations.[1]

The case was on appeal from the U.S. Court of Appeals for the Federal Circuit and raised the question of whether the Supreme Court should overturn the Auer deference doctrine stemming from the Auer v. Robbins and Bowles v. Seminole Rock & Sand Co. decisions. Auer deference provides that an agency's interpretation of its own regulations is controlling unless the interpretation is erroneous or inconsistent with the regulations being interpreted.[2]...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.

  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!


Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!